Cleared Traditional

ADDITIONAL HEMOTEC ACT COAGULATION CARTRIDGES (K853198) - FDA 510(k) Clearance

Class II Hematology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K853198 · Medical Device Consultants, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1985
Decision
66d
Days
Class 2
Risk

K853198 is an FDA 510(k) clearance for the ADDITIONAL HEMOTEC ACT COAGULATION CARTRIDGES. Classified as System, Multipurpose For In Vitro Coagulation Studies (product code JPA), Class II - Special Controls.

Submitted by Medical Device Consultants, Inc. (North Attleboro, US). The FDA issued a Cleared decision on October 4, 1985 after a review of 66 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5425 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medical Device Consultants, Inc. devices

Submission Details

510(k) Number K853198 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 30, 1985
Decision Date October 04, 1985
Days to Decision 66 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 113d · This submission: 66d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JPA System, Multipurpose For In Vitro Coagulation Studies
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - JPA System, Multipurpose For In Vitro Coagulation Studies

All 61
Devices cleared under the same product code (JPA) and FDA review panel - the closest regulatory comparables to K853198.
ACL SYSTEMS 100, 200, 300 AND 300+ COAGULATION SYS
K881367 · Instrumentation Laboratory CO · Jun 1988
CHROM-TROL
K872377 · Helena Laboratories · Jul 1987
IL TEST 84673-30 CHROMOGENICS CONTROL PLASMA
K864271 · Instrumentation Laboratory CO · Nov 1986
DUPONT ACA PROTHROMBIN TIME/ACTIVATED PARTIAL THRO
K851127 · E.I. Dupont DE Nemours & Co., Inc. · May 1985
COBAS-FIBRO
K842717 · Roche Diagnostic Systems, Inc. · Oct 1984
NORM-TROL
K792310 · Helena Laboratories · Dec 1979